D
Dis-Chem Pharmacies Ltd
JSE:DCP
Dis-Chem Pharmacies Ltd
JSE:DCP
Price:
3 682
Zac
-0.08%
Market Closed
Market Cap:
31.7B
ZAR
Balance Sheet
Balance Sheet Decomposition
Dis-Chem Pharmacies Ltd
Dis-Chem Pharmacies Ltd
Balance Sheet Decomposition is not available for
Dis-Chem Pharmacies Ltd
Dis-Chem Pharmacies Ltd
Balance Sheet
Dis-Chem Pharmacies Ltd
Dis-Chem Pharmacies Ltd
Currency: ZAR
| Feb-2014 | Feb-2015 | Feb-2016 | Feb-2017 | Feb-2018 | Feb-2019 | Feb-2020 | Feb-2021 | Feb-2022 | Feb-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
23
|
27
|
273
|
295
|
280
|
177
|
452
|
540
|
706
|
287
|
|
| Cash |
23
|
27
|
273
|
295
|
0
|
177
|
452
|
540
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
280
|
0
|
0
|
0
|
706
|
287
|
|
| Total Receivables |
579
|
0
|
1 022
|
1 134
|
1 243
|
1 470
|
1 741
|
2 047
|
2 265
|
2 615
|
|
| Accounts Receivables |
399
|
0
|
452
|
539
|
1 119
|
521
|
616
|
702
|
875
|
1 330
|
|
| Other Receivables |
180
|
0
|
570
|
595
|
124
|
949
|
1 125
|
1 345
|
1 391
|
1 284
|
|
| Inventory |
1 925
|
0
|
2 807
|
3 234
|
3 948
|
5 116
|
4 507
|
5 691
|
5 759
|
6 357
|
|
| Other Current Assets |
71
|
82
|
3
|
42
|
0
|
86
|
132
|
142
|
124
|
189
|
|
| Total Current Assets |
2 598
|
82
|
4 105
|
4 705
|
5 471
|
6 849
|
6 832
|
8 420
|
8 854
|
9 448
|
|
| PP&E Net |
208
|
0
|
919
|
995
|
2 815
|
2 995
|
3 095
|
3 716
|
3 689
|
4 429
|
|
| PP&E Gross |
208
|
0
|
919
|
995
|
0
|
2 995
|
3 095
|
3 716
|
3 689
|
4 429
|
|
| Accumulated Depreciation |
443
|
560
|
628
|
743
|
0
|
2 136
|
2 541
|
2 931
|
3 650
|
4 526
|
|
| Intangible Assets |
5
|
0
|
15
|
11
|
300
|
244
|
229
|
400
|
419
|
397
|
|
| Goodwill |
20
|
20
|
20
|
29
|
0
|
203
|
227
|
498
|
791
|
874
|
|
| Long-Term Investments |
2
|
0
|
2
|
0
|
0
|
0
|
14
|
13
|
183
|
194
|
|
| Other Long-Term Assets |
123
|
0
|
109
|
156
|
236
|
231
|
189
|
141
|
140
|
174
|
|
| Other Assets |
20
|
20
|
20
|
29
|
0
|
203
|
227
|
498
|
791
|
874
|
|
| Total Assets |
2 957
N/A
|
0
N/A
|
5 170
N/A
|
5 897
+14%
|
8 822
+50%
|
10 521
+19%
|
10 587
+1%
|
13 188
+25%
|
14 075
+7%
|
15 516
+10%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1 182
|
1 191
|
1 681
|
2 369
|
3 238
|
4 131
|
3 990
|
5 184
|
5 377
|
5 419
|
|
| Accrued Liabilities |
59
|
0
|
102
|
129
|
146
|
216
|
312
|
340
|
398
|
448
|
|
| Short-Term Debt |
61
|
0
|
1 530
|
167
|
308
|
679
|
169
|
418
|
684
|
817
|
|
| Current Portion of Long-Term Debt |
348
|
0
|
30
|
176
|
454
|
459
|
476
|
628
|
662
|
995
|
|
| Other Current Liabilities |
106
|
0
|
165
|
403
|
136
|
234
|
217
|
220
|
392
|
671
|
|
| Total Current Liabilities |
1 755
|
1 191
|
3 508
|
3 244
|
4 282
|
5 719
|
5 163
|
6 789
|
7 514
|
8 350
|
|
| Long-Term Debt |
3
|
0
|
652
|
1 270
|
2 938
|
2 789
|
3 054
|
3 430
|
3 161
|
3 162
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
22
|
35
|
16
|
14
|
71
|
|
| Minority Interest |
64
|
0
|
117
|
24
|
51
|
64
|
61
|
43
|
62
|
32
|
|
| Other Liabilities |
194
|
0
|
171
|
252
|
55
|
41
|
19
|
0
|
0
|
0
|
|
| Total Liabilities |
2 015
N/A
|
0
N/A
|
4 447
N/A
|
4 790
+8%
|
7 326
+53%
|
8 636
+18%
|
8 333
-4%
|
10 279
+23%
|
10 751
+5%
|
11 615
+8%
|
|
| Equity | |||||||||||
| Common Stock |
178
|
0
|
1 352
|
6 141
|
6 156
|
6 156
|
6 156
|
6 156
|
6 156
|
6 156
|
|
| Retained Earnings |
763
|
0
|
630
|
5 034
|
4 659
|
4 270
|
3 902
|
3 247
|
2 832
|
2 255
|
|
| Total Equity |
942
N/A
|
0
N/A
|
723
N/A
|
1 107
+53%
|
1 496
+35%
|
1 886
+26%
|
2 253
+20%
|
2 909
+29%
|
3 324
+14%
|
3 900
+17%
|
|
| Total Liabilities & Equity |
2 957
N/A
|
0
N/A
|
5 170
N/A
|
5 897
+14%
|
8 822
+50%
|
10 521
+19%
|
10 587
+1%
|
13 188
+25%
|
14 075
+7%
|
15 516
+10%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
180
|
0
|
794
|
859
|
860
|
860
|
860
|
860
|
860
|
860
|
|
Switch to:
Switch to:
See Also
Discover More
